← Open Payments lookup

WHITNEY BEISWANGER: Open Payments

NPI 1629749437 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,026 in 57 payments from 16 companies in 2025. Trend: 2023 $1,561 · 2024 $1,431 · 2025 $1,026

Food & beverage: $1,026
CompanyPaymentsAmount
ABBVIE INC.21$287
AstraZeneca Pharmaceuticals LP7$208
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$145
Novo Nordisk Inc4$81
Otsuka America Pharmaceutical, Inc.3$70
Axsome Therapeutics, Inc.2$44
Bayer Healthcare Pharmaceuticals Inc.2$43
Corcept Therapeutics1$22
Abbott Laboratories1$21
Sumitomo Pharma America, Inc.1$21

Products named: BREZTRI, CAPLYTA, VRAYLAR, REXULTI, QULIPTA, LINZESS, Ozempic, Auvelity.

Industry payments across IN — which companies pay providers there.